TABLE 5

Carboxydichlorofluorescein pharmacokinetic and excretory parameters

Data are means ± S.D. n = 4 to 6.

ParameterWild TypeMrp2 KOBcrp KOMdr1a KO
Carboxydichlorofluorescein (3 mg/kg i.v.; bile duct-intact rats)
    AUCinf, μg · h/ml31.6 ± 3.941.8 ± 4.5*22.8 ± 4.2*22.6 ± 4.0*
    CL, ml · min−1 · kg−11.6 ± 0.21.2 ± 0.1*2.3 ± 0.5*2.3 ± 0.3*
    VD, SS, ml/kg170 ± 8190 ± 20184 ± 22192 ± 18
    t1/2, h1.4 ± 0.21.9 ± 0.2*1.1 ± 0.11.2 ± 0.1
Carboxydichlorofluorescein (3 mg/kg i.v.; bile duct-cannulated rats)
    Xurine0–4 h, % dosea30 ± 1461 ± 2452 ± 15N/A
    Xbile0–4 h, % dose56 ± 210 ± 0*45 ± 18N/A
    Total0–4 h, % dose86 ± 2361 ± 2497 ± 19N/A
    Xurine0–4 h, % dosea34 ± 11N/AN/A32 ± 20
    Xbile0–4 h, % dose20 ± 11N/AN/A18 ± 18
    Total0–4 h, % dose54 ± 5N/AN/A50 ± 23
  • KO, knockout; AUCinf, area under the curve extrapolated to infinity; CL, clearance; VD, SS, volume of distribution; t1/2, half-life; X, amount excreted; N/A, not applicable. .

  • * p < 0.05.

  • a Amount excreted in urine also includes urine dried on the side of the metabolic cage, which was recovered in the cage wash at the end of the study.